HIV/AIDS Clinical Trials in Philadelphia

Showing 261-280 of 315 trials

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

NCT00006290

The purpose of this study is to learn how changes in body build affect the lives of people taking anti-HIV medications. By learning this, a set of questions can be created to help understand how changes in body build and image affect people living with HIV infection. A set of questions used to measure body image might be useful in future HIV studies. It may help doctors understand patient concerns about their body image and why some patients stop taking their anti-HIV medications.

HIV InfectionsLipodystrophy

National Institute of Allergy and Infectious Diseases (NIAID)60 participants

San Diego, California, United States • Baltimore, Maryland, United States • Columbus, Ohio, United States +1 more locations

COMPLETEDPHASE1< 1 mile

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

NCT00004736

The purpose of this study is to see if a type of anti-HIV therapy called HAART is effective in lowering levels of HIV and boosting the immune system in HIV-infected patients with tuberculosis (TB). HIV-infected patients with TB have higher levels of HIV and lower CD4 cell counts (cells in the body that fight infection) than HIV-infected patients without TB. HAART has been effective in reducing HIV levels and increasing CD4 cells in patients without TB. However, its effects in HIV-infected patients with TB are unknown.

HIV InfectionsTuberculosis

National Institute of Allergy and Infectious Diseases (NIAID)44 participants

Los Angeles, California, United States • San Diego, California, United States • Chicago, Illinois, United States +7 more locations

Perceived Changes in Body Build and Image in Patients Who Are Now Taking or Recently Have Stopped Taking Anti-HIV Drugs

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

HIV/AIDS Trials in Other Cities

A Study to Evaluate the Effects of Anti-HIV Drugs in HIV-Positive Patients Who Also Have Hepatitis C Infection

A Blood Test to Look at Cells of the Immune System in Healthy Children

Comparing Single Photon Emission Computed Tomography (SPECT) and Liver Biopsy to Evaluate the Liver in Patients With HIV and Hepatitis C Virus

Ritonavir-Boosted GS-9137 vs. Ritonavir-Boosted Protease Inhibitor(s) in Combination With Background ART.

An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare Spots

The Effects of Treatment for Mycobacterium Avium Complex (MAC) on the Cells of HIV-Infected Patients

A Study of the Safety and Effectiveness of Combination Anti-HIV Therapy in HIV-Infected Adults

Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC

A Study of ddI in Patients With AIDS Who Become Sicker While Taking Zidovudine

TBTC Study 23A: Pharmacokinetics of Intermittent Isoniazid and Rifabutin in HIV-TB

TBTC Study 23B:Intensive PK of the Nelfinavir Rifabutin Interaction in Patients With HIV-TB

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

Buprenorphine and Integrated HIV Care Evaluation

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

The Safety and Effectiveness of HBY 097 Used With or Without AZT in HIV-Infected Patients Who Have Mild or No Symptoms

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors

Study Comparing Racivir and Lamivudine in Treatment-Experienced HIV Subjects

Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs

Other Conditions in Philadelphia